Central Australian Aboriginal women's pregnancy, labour and birth outcomes following maternal smokeless tobacco (pituri) use, cigarette use or no-tobacco use: a prospective cohort study.
Australian Aboriginal and Torres Strait Islander people
Central Australia
Maternal outcomes
Pituri
Pregnancy
Smokeless tobacco
Smoking
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
28 04 2021
28 04 2021
Historique:
received:
31
01
2021
accepted:
15
04
2021
entrez:
29
4
2021
pubmed:
30
4
2021
medline:
25
5
2021
Statut:
epublish
Résumé
Outcomes related to maternal smoked tobacco (cigarette) use have been substantially examined over the past 50 years with resultant public health education targeted towards the reduction of use during pregnancy. However, worldwide the effects of maternal smokeless tobacco use have been less well explored and in Australia, there has been no examination of maternal outcomes in relation to the use of Australian Nicotiana spp. (tobacco plant) as a smokeless tobacco, colloquially known as pituri. The aim of this study is to describe the maternal outcomes of a group of central Australian Aboriginal women in relation to their self-reported tobacco use. Eligible participants were > 18 years of age, with a singleton pregnancy, > 28 weeks gestation, and who planned to birth at the Alice Springs Hospital (the major regional hospital for central Australia, in the Northern Territory, Australia). The sample consisted of 73 conveniently recruited women categorized by tobacco-use status as no-tobacco users (n = 31), pituri chewers (n = 19), and smokers (n = 23). There were differences in the groups in relation to teenage pregnancies; 35% of no-tobacco users, compared with 5% of pituri users, and 13% of smokers were < 20 years of age. The chewers had a higher rate (48%) of combined pre-existing and pregnancy-related elevated glucose concentrations compared with smokers (22%) and no-tobacco users (16%).The pituri chewers had the lowest rate (14%) of clinically significant post-partum hemorrhage (> 1000 ml) compared with 22% of smokers and 36% of the no-tobacco users. This is the first research to examine pituri use in pregnancy and the findings indicate possible associations with a range of adverse maternal outcomes. The use of smokeless tobacco needs to be considered in maternal healthcare assessment to inform antenatal, intrapartum and postpartum care planning. Female smokeless tobacco use is a global phenomenon and is particularly prevalent in low and middle income countries and in Indigenous populations. The findings contribute to the developing knowledge around maternal smokeless tobacco use and maternal outcomes. Maternal screening for a broader range of tobacco and nicotine products is required. In this research, the central Australian Aboriginal women chose the term 'Aboriginal' to refer to themselves, and 'Indigenous' to refer to the broader First Peoples. That choice has been maintained in the reporting of the research findings.
Sections du résumé
BACKGROUND
Outcomes related to maternal smoked tobacco (cigarette) use have been substantially examined over the past 50 years with resultant public health education targeted towards the reduction of use during pregnancy. However, worldwide the effects of maternal smokeless tobacco use have been less well explored and in Australia, there has been no examination of maternal outcomes in relation to the use of Australian Nicotiana spp. (tobacco plant) as a smokeless tobacco, colloquially known as pituri. The aim of this study is to describe the maternal outcomes of a group of central Australian Aboriginal women in relation to their self-reported tobacco use.
METHODS
Eligible participants were > 18 years of age, with a singleton pregnancy, > 28 weeks gestation, and who planned to birth at the Alice Springs Hospital (the major regional hospital for central Australia, in the Northern Territory, Australia). The sample consisted of 73 conveniently recruited women categorized by tobacco-use status as no-tobacco users (n = 31), pituri chewers (n = 19), and smokers (n = 23).
RESULTS
There were differences in the groups in relation to teenage pregnancies; 35% of no-tobacco users, compared with 5% of pituri users, and 13% of smokers were < 20 years of age. The chewers had a higher rate (48%) of combined pre-existing and pregnancy-related elevated glucose concentrations compared with smokers (22%) and no-tobacco users (16%).The pituri chewers had the lowest rate (14%) of clinically significant post-partum hemorrhage (> 1000 ml) compared with 22% of smokers and 36% of the no-tobacco users.
CONCLUSIONS
This is the first research to examine pituri use in pregnancy and the findings indicate possible associations with a range of adverse maternal outcomes. The use of smokeless tobacco needs to be considered in maternal healthcare assessment to inform antenatal, intrapartum and postpartum care planning.
IMPLICATIONS FOR PUBLIC HEALTH
Female smokeless tobacco use is a global phenomenon and is particularly prevalent in low and middle income countries and in Indigenous populations. The findings contribute to the developing knowledge around maternal smokeless tobacco use and maternal outcomes. Maternal screening for a broader range of tobacco and nicotine products is required.
NOTE TO READERS
In this research, the central Australian Aboriginal women chose the term 'Aboriginal' to refer to themselves, and 'Indigenous' to refer to the broader First Peoples. That choice has been maintained in the reporting of the research findings.
Identifiants
pubmed: 33910555
doi: 10.1186/s12889-021-10872-z
pii: 10.1186/s12889-021-10872-z
pmc: PMC8082654
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
814Références
Indian J Community Med. 2010 Jan;35(1):14-8
pubmed: 20606913
Toxicol Lett. 2016 Jul 8;254:45-51
pubmed: 27178269
Obstet Gynecol. 2000 Nov;96(5 Pt 1):741-8
pubmed: 11042311
Am J Obstet Gynecol. 2009 Apr;200(4):415.e1-5
pubmed: 19070830
Fetal Diagn Ther. 2017;41(4):241-250
pubmed: 28249267
Diabetes Care. 2014 Dec;37(12):3164-71
pubmed: 25336749
Diabetes Care. 2014 Sep;37(9):2442-50
pubmed: 24947793
Int J Public Health. 2014 Aug;59(4):599-608
pubmed: 24794708
Diabetol Metab Syndr. 2016 Mar 08;8:21
pubmed: 26958082
Med Hist. 1967 Jul;11(3):228-68
pubmed: 4864420
Front Biosci. 2007 Jan 01;12:2471-83
pubmed: 17127256
Am J Obstet Gynecol. 1957 Apr;73(4):807-15
pubmed: 13411046
Front Genet. 2019 Sep 05;10:770
pubmed: 31616461
Clin Pharmacol Ther. 1988 Jul;44(1):23-8
pubmed: 3391001
PLoS One. 2016 Jun 20;11(6):e0157592
pubmed: 27322410
Ann Intern Med. 2000 Oct 17;133(8):585-91
pubmed: 11033585
Am J Obstet Gynecol. 2002 May;186(5):1035-40
pubmed: 12015533
Acta Obstet Gynecol Scand. 2010;89(4):531-9
pubmed: 20230310
Hypertension. 2010 May;55(5):1254-9
pubmed: 20231527
Obstet Gynecol. 2011 Jul;118(1):29-38
pubmed: 21646928
Diabetes Care. 1994 Jul;17(7):688-92
pubmed: 7924778
Taiwan J Obstet Gynecol. 2019 Jul;58(4):454-459
pubmed: 31307732
Methods Protoc. 2019 Jun 07;2(2):
pubmed: 31181680
Pediatr Res. 2012 Jul;72(1):101-7
pubmed: 22441375
J Ethnobiol Ethnomed. 2010 Sep 12;6:26
pubmed: 20831827
Semin Perinatol. 1996 Apr;20(2):115-26
pubmed: 8857697
Nicotine Tob Res. 2008 May;10(5):917-20
pubmed: 18569767
Am J Obstet Gynecol. 1992 Dec;167(6):1624-31
pubmed: 1471677
Scand J Public Health. 2012 Dec;40(8):730-7
pubmed: 23117209
Annu Rev Nutr. 2002;22:35-59
pubmed: 12055337
Diabetes Care. 2014 Nov;37(11):2966-73
pubmed: 25092685
Acta Obstet Gynecol Scand. 2010;89(4):465-77
pubmed: 20225988
Nicotine Tob Res. 2016 Jan;18(1):79-83
pubmed: 25895950
N Engl J Med. 1984 Sep 6;311(10):672
pubmed: 6472348
Nicotine Tob Res. 2004 Apr;6 Suppl 2:S125-40
pubmed: 15203816
Prev Med. 2010 Jan-Feb;50(1-2):13-8
pubmed: 20026103
Kidney Int. 2001 Jul;60(1):249-56
pubmed: 11422758
Am J Epidemiol. 2004 Dec 15;160(12):1205-13
pubmed: 15583373
Drug Alcohol Rev. 2018 Mar;37(3):414-420
pubmed: 28543690
Expert Rev Obstet Gynecol. 2008 Nov 1;3(6):719-730
pubmed: 19881889
Scand J Public Health. 2006;34(6):576-83
pubmed: 17132590
Am J Epidemiol. 2011 Feb 1;173(3):355-9
pubmed: 21178103
Rural Remote Health. 2017 Jul-Sep;17(3):4044
pubmed: 28780876
Ital J Pediatr. 2013 Jan 23;39:7
pubmed: 23343462
J Paediatr Child Health. 2015 Oct;51(10):982-7
pubmed: 25940598
Hypertension. 2010 May;55(5):1100-1
pubmed: 20231524
Diabetes Care. 2011 Apr;34(4):892-7
pubmed: 21355099
Am J Public Health. 1993 Feb;83(2):211-4
pubmed: 8427325
Acta Diabetol. 2014 Oct;51(5):793-9
pubmed: 24934227
Drug Alcohol Rev. 1991;10(4):367-80
pubmed: 16818300
Nicotine Tob Res. 2015 Sep;17(9):1058-66
pubmed: 25534929
Women Birth. 2018 Apr;31(2):89-95
pubmed: 28838805
Metabolism. 1996 Dec;45(12):1551-6
pubmed: 8969291
Neurotoxicol Teratol. 2008 Jan-Feb;30(1):1-19
pubmed: 18380035
Diabetes Care. 2006 Aug;29(8):1788-93
pubmed: 16873781
Am J Public Health. 2008 Oct;98(10):1833-40
pubmed: 18309125
J Intern Med. 2000 Aug;248(2):103-10
pubmed: 10947888
JAMA. 1997 Oct 1;278(13):1078-83
pubmed: 9315766
Am J Obstet Gynecol. 2007 Sep;197(3):275.e1-5
pubmed: 17826418
BJOG. 2014 Jun;121(7):876-88
pubmed: 24517180
Transl Res. 2017 Jun;184:101-107
pubmed: 28336465
Toxicol Sci. 2010 Aug;116(2):364-74
pubmed: 20363831
Paediatr Perinat Epidemiol. 2012 Jan;26(1):70-6
pubmed: 22150710
BMJ. 2009 Oct 29;339:b4347
pubmed: 19875845
Acta Obstet Gynecol Scand. 2013 Jun;92(6):648-55
pubmed: 23551054
JAMA. 2007 Dec 12;298(22):2654-64
pubmed: 18073361
BMJ Open. 2013 Jan 24;3(1):
pubmed: 23355667
Am J Obstet Gynecol. 2003 Oct;189(4):939-43
pubmed: 14586330
Diabetes Care. 2007 Jul;30 Suppl 2:S112-9
pubmed: 17596458
Indian J Med Res. 2006 Sep;124(3):261-8
pubmed: 17085829
J Ayub Med Coll Abbottabad. 2008 Apr-Jun;20(2):110-3
pubmed: 19385472
Am J Obstet Gynecol. 1999 Oct;181(4):1026-35
pubmed: 10521771
Indian J Endocrinol Metab. 2012 Jan;16(1):81-7
pubmed: 22276256